Depression and anxiety among transgender individuals Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults (aged =18 years) 2. Self-identifying as transgender 3. Residing in district Peshawar 4. Possessing a valid national identity card 5. Positive screen for both depression and anxiety, defined as scores =3 on the Patient Health Questionnaire-2 (PHQ-2) and Generalized Anxiety Disorder-2 (GAD-2)
Exclusion criteria
Exclusion criteria: Individuals already engaged in ongoing psychiatric or psychological treatment at study onset will be excluded to avoid confounding treatment effects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Depressive symptoms measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline (pre-intervention), 2-month follow-up, and 4-month follow-up 2. Anxiety symptoms measured using the Generalized Anxiety Disorder-7 (GAD-7) at baseline (pre-intervention), 2-month follow-up, and 4-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Feasibility and process outcomes: 1. Recruitment rate: number and proportion of eligible participants who consent and enroll, measured at baseline. 2. Retention rate: number and proportion of participants completing both follow-up assessments at 2 and 4 months. 3. Treatment adherence: number and proportion of participants attending all three scheduled mhGAP-based CBT sessions. Participants missing no more than one session are classified as “adherent”; others as “non-adherent.” Measured at 4 months post-intervention, based on GP session logs. | — |
Countries
Pakistan
Contacts
;